Figure 5
Figure 5. TPO-induced signaling is enhanced in Cib1−/− megakaryocytes. (A) Western blots of lysates from untreated or TPO-treated WT and Cib1−/− BM-derived megakaryocytes purified using a discontinuous BSA gradient. Membranes were initially probed for phosphorylated AktT308 and phosphorylated ERK1/2, then stripped and reprobed for total Akt or total ERK1/2, respectively. (B) Quantification of band intensity from panel A normalized to untreated WT sample. *P < .05 vs WT + TPO (n = 5). (C) Western blots of lysates from WT and Cib1−/− megakaryocytes treated with or without TPO. Membranes were probed for phosphorylated FAKY925, then stripped and reprobed for total FAK. (D) Quantification of band intensity from panel B, normalized to untreated WT sample. *P < .05 vs WT + TPO (n = 5).

TPO-induced signaling is enhanced in Cib1−/− megakaryocytes. (A) Western blots of lysates from untreated or TPO-treated WT and Cib1−/− BM-derived megakaryocytes purified using a discontinuous BSA gradient. Membranes were initially probed for phosphorylated AktT308 and phosphorylated ERK1/2, then stripped and reprobed for total Akt or total ERK1/2, respectively. (B) Quantification of band intensity from panel A normalized to untreated WT sample. *P < .05 vs WT + TPO (n = 5). (C) Western blots of lysates from WT and Cib1−/− megakaryocytes treated with or without TPO. Membranes were probed for phosphorylated FAKY925, then stripped and reprobed for total FAK. (D) Quantification of band intensity from panel B, normalized to untreated WT sample. *P < .05 vs WT + TPO (n = 5).

Close Modal

or Create an Account

Close Modal
Close Modal